サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ビタミンD療法の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1176013

ビタミンD療法の世界市場 - 成長、将来展望、競合分析（2022年～2030年）

Vitamin D Therapy Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ビタミンD療法の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月22日
発行: Acute Market Reports
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のビタミンD療法の市場規模は、2021年の25億7,280万米ドルから、2030年には63億2,950万米ドルに達する見通しで、2022年から2030年までの予測期間中に10.6%のCAGRで成長すると予測されています。

当レポートでは、世界のビタミンD療法市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポート概要
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界のビタミンD療法市場
  • 世界のビタミンD療法市場、用途別（2021年、金額）
  • 世界のビタミンD療法市場、地域別（2021年、金額）
  • COVID-19の影響
  • 魅力的な投資提案：地域別（2021年）
  • 競合分析
    • 主要ビタミンD療法市場ベンダーの市場ポジショニング
    • ビタミンD療法市場ベンダーの採用戦略
    • 主要業界戦略

第3章 ビタミンD療法市場：ビジネスの見通しと市場力学

  • イントロダクション
  • 世界のビタミンD療法市場（2020年～2030年、金額）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 ビタミンD療法市場：用途別（2020年～2030年、金額）

  • 市場概要
  • 成長と収益分析（2021年、2030年）
  • 市場セグメンテーション
    • 骨粗鬆症
    • くる病
    • 自己免疫疾患
    • 皮膚疾患

第5章 北米のビタミンD療法市場（2020年～2030年、金額）

  • 市場概要
  • ビタミンD療法市場：用途別（2020年～2030年、金額）
  • ビタミンD療法市場：地域別（2020年～2030年、金額）
    • 北米

第6章 英国・欧州連合のビタミンD療法市場（2020年～2030年、金額）

  • 市場概要
  • ビタミンD療法市場：用途別（2020年～2030年、金額）
  • ビタミンD療法市場：地域別（2020年～2030年、金額）
    • 英国・欧州連合

第7章 アジア太平洋地域のビタミンD療法市場（2020年～2030年、金額）（100万米ドル）

  • 市場概要
  • ビタミンD療法市場：用途別（2020年～2030年、金額）
  • ビタミンD療法市場：地域別（2020年～2030年、金額）
    • アジア太平洋地域

第8章 ラテンアメリカのビタミンD療法市場（2020年～2030年、金額）

  • 市場概要
  • ビタミンD療法市場：用途別（2020年～2030年、金額）
  • ビタミンD療法市場：地域別（2020年～2030年、金額）
    • ラテンアメリカ

第9章 中東・アフリカのビタミンD療法市場（2020年～2030年、金額）

  • 市場概要
  • ビタミンD療法市場：用途別（2020年～2030年、金額）
  • ビタミンD療法市場：地域別（2020年～2030年、金額）
    • 中東・アフリカ

第10章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Alkem Laboratories
  • Cadila Healthcare Ltd.
  • GlaxoSmithkline, Plc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
図表

List of Tables

  • TABLE 1 Global Vitamin D Therapy Market By Application, 2020-2030, USD (Million)
  • TABLE 2 North America Vitamin D Therapy Market By Application, 2020-2030, USD (Million)
  • TABLE 3 UK and European Union Vitamin D Therapy Market By Application, 2020-2030, USD (Million)
  • TABLE 4 Asia Pacific Vitamin D Therapy Market By Application, 2020-2030, USD (Million)
  • TABLE 5 Latin America Vitamin D Therapy Market By Application, 2020-2030, USD (Million)
  • TABLE 6 Middle East and Africa Vitamin D Therapy Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Vitamin D Therapy Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Vitamin D Therapy Market: Quality Assurance
  • FIG. 5 Global Vitamin D Therapy Market, By Application, 2021
  • FIG. 6 Global Vitamin D Therapy Market, By Geography, 2021
  • FIG. 7 Global Vitamin D Therapy Market, By Application, 2021 Vs 2030, %
  • FIG. 8 U.S. Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 15 France Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 17 China Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 19 India Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Vitamin D Therapy Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Vitamin D Therapy Market (US$ Million), 2020 - 2030
目次
Product Code: 138709-08-22

Industry Outlook

The vitamin D therapy market is set to reach US$ 6329.5 Mn by 2030 from US$ 2572.8 Mn in 2021 showcasing spectacular growth at a compounded annual growth rate (CAGR) of 10.6% during the forecast period from 2022 to 2030. As per the research findings of International Osteoporosis Foundation (IOF), one in three women and one in five men above the age of 50 years is prone to suffer with fracture during their lifetime. Malnourishment, increasing consumption of alcohol & tobacco and hormonal imbalance are causing bone and skin disorders associated with vitamin D deficiency.

Excellent pharmacokinetic and pharmacodynamic drug profile will help parenteral route to register faster growth

Oral route of administration is reigning the vitamin D therapy market in the present scenario. It is very popular in children due to ease of administration and formulated in different sizes and colors which increases its external aesthetic appeal hence increasing its palatability in childrens. It is also beneficial in improving vitamin D levels in adults with no systemic illness. Parenteral route are gaining traction on account of its inherent features such as excellent pharmacokinetic and pharmacodynamic drug profile useful in elderly patients suffering with impaired vitamin D absorption via the gastrointestinal tract.

Increasing consumption of diet deficient in vitamin D & calcium and hormonal imbalance causes osteoporosis with progressive ageing in humans

Osteoporosis is currently dominating the applications segment for vitamin D therapy market. As per the latest statistics provided by International Osteoporosis Foundation (IOF), globally osteoporosis causes 8.9 million bone fracture occurring at every 3 seconds. The risk factors associated with osteoporosis is increasing consumption of diet efficient in calcium and Vitamin D and hormonal imbalance with progressive ageing in humans. The occurrence rate is high in female as compared to the male population. Malnutrition is causing rickets in children at an early age in the developing and poor countries. Skin disease are garnering huge traction on account of huge deletion of ozone layers causes the harmful UV radiation to skin surface depleting keratinocytes useful in Vitamin D3 synthesis in skin. Skin inflammatory diseases such as atopic dermatitis and psoriasis are associated with depleting levels of skin vitamin D levels.

Rising prevalence of osteoporosis & low bone mass and increasing public health awareness drive the market growth in North America region

North America is currently representing 33% market share in the regional segment for vitamin D therapy market. The major factors influencing its market growth are rising prevalence of osteoporosis and low bone mass. According to the research findings brought forward by National Osteoporosis Foundation (NOF), approximately one half of the total adult population in the United States is suffering with osteoporosis. Increasing public health awareness in the region will further propel the market growth. Europe is in the second place holding 30% market share owing to rising prevalence of skin disorders associated with low serum cholecalciferol levels. Favorable reimbursement scenario associated with vitamin D therapy consolidates the market growth in European Region. Asia Pacific accounts for 20% market share primarily due to rising prevalence of malnutrition in children causing rickets at an early age. Presence of major players such as GlaxoSmithkline, Plc., Torrent Pharmaceuticals Ltd., Cadila Healthcare, Alkem Laboratories etc. drive the market growth in Asia Pacific region.

Pharmaceutical companies providing vitamin D therapy are: Abbott Laboratories, Inc., Alkem Laboratories, Cadila Healthcare Ltd., GlaxoSmithkline, Plc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Torrent Pharmaceutical Ltd.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Vitamin D Therapy market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Vitamin D Therapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Application

  • Osteoporosis
  • Rickets
  • Autoimmune Disorder
  • Skin Disease

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Vitamin D Therapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Vitamin D Therapy market?
  • Which is the largest regional market for Vitamin D Therapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Vitamin D Therapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Vitamin D Therapy market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Vitamin D Therapy Market
  • 2.2. Global Vitamin D Therapy Market, By Application, 2021 (US$ Million)
  • 2.3. Global Vitamin D Therapy Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Vitamin D Therapy Market Vendors
    • 2.6.2. Strategies Adopted by Vitamin D Therapy Market Vendors
    • 2.6.3. Key Industry Strategies

3. Vitamin D Therapy Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Vitamin D Therapy Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Osteoporosis
    • 4.3.2. Rickets
    • 4.3.3. Autoimmune Disorder
    • 4.3.4. Skin Disease

5. North America Vitamin D Therapy Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)
  • 5.3.Vitamin D Therapy Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Vitamin D Therapy Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)
  • 6.3.Vitamin D Therapy Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Vitamin D Therapy Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)
  • 7.3.Vitamin D Therapy Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Vitamin D Therapy Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)
  • 8.3.Vitamin D Therapy Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Vitamin D Therapy Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Vitamin D Therapy Market: By Application, 2020-2030, USD (Million)
  • 9.3.Vitamin D Therapy Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. Abbott Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Alkem Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Cadila Healthcare Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. GlaxoSmithkline, Plc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Merck & Co., Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. Novartis AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Pfizer, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. Sanofi S.A.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Sun Pharmaceutical Industries Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Torrent Pharmaceuticals Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives